Chemical Property of Larotaxel
Edit
Chemical Property:
- Boiling Point:889.3±65.0 °C(Predicted)
- PKA:11.20±0.46(Predicted)
- PSA:213.78000
- Density:1.37
- LogP:4.67390
- Storage Temp.:-20°C Freezer
- Solubility.:Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
- XLogP3:2.7
- Hydrogen Bond Donor Count:3
- Hydrogen Bond Acceptor Count:14
- Rotatable Bond Count:15
- Exact Mass:831.34660536
- Heavy Atom Count:60
- Complexity:1790
- Purity/Quality:
-
97% *data from raw suppliers
Larotaxel *data from reagent suppliers
Safty Information:
- Pictogram(s):
- Hazard Codes:
- MSDS Files:
-
SDS file from LookChem
Useful:
- Canonical SMILES:CC1=C2C(C(=O)C34CC3CC5C(C4C(C(C2(C)C)(CC1OC(=O)C(C(C6=CC=CC=C6)NC(=O)OC(C)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO5)OC(=O)C)OC(=O)C
- Isomeric SMILES:CC1=C2[C@H](C(=O)[C@]34C[C@H]3C[C@@H]5[C@]([C@H]4[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C6=CC=CC=C6)NC(=O)OC(C)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO5)OC(=O)C)OC(=O)C
- Recent ClinicalTrials:Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen
- Recent EU Clinical Trials:Randomized Study of LAROTAXEL + Cisplatin (LC) vs. Gemcitabine + Cisplatin (GC) in the First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
-
Uses
Larotaxel (RPR 109881A) is a taxane analog with a broad spectrum of activity and different toxicity profile and with the possible advantages of surpassing some mechanisms of resistance and penetrating into the CNS.